drug discovery Archive — Page 2 of 3

Silhouetted person wearing a backpack and looking through binoculars while standing on a grassy ridge against an orange sky.
May 5, 2016

Current cancer drug discovery method flawed: VUMC study

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

Young man sleeping on his side with his head on a white pillow, partially covered by white bedding.
March 21, 2016

Putting schizophrenia to bed

A new compound developed at Vanderbilt treats multiple symptoms of schizophrenia in an animal model, without causing sedation.

Seven officials pose for a group photo in an office or institutional setting, with six standing in front and one taller person behind them.
December 10, 2015

Vanderbilt, Ono Pharmaceutical sign drug discovery agreement

Vanderbilt University Medical Center and Ono Pharmaceutical Group, an international company based in Japan, have signed a drug discovery agreement.

aspergillus culture
October 7, 2015

Rational design of novel antifungals

Structural and molecular details of an anti-fungal target’s interaction with inhibitors suggest ways to design better treatments for fungal infections.

Five researchers pose together in a bright university building, with one wearing a white lab coat and the others in business-casual clothing.
October 1, 2015

Collaboration seeks to develop new therapies for bone, other diseases

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.

Assorted brightly colored capsules scattered on a white background.
July 15, 2015

Drug signaling networks

Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action.